Anticoagulant: avoid CPD [Bioanalytics]

posted by Ohlbe – France, 2012-06-19 19:44 (5120 d 13:12 ago) – Posting: # 8802
Views: 10,264

Dear Constantinos,

I fully agree with Helmut, and particularly in the case of CPD. The problem with CPD plasma is the large volume of buffer added to blood. It basically results in a 30 % dilution of plasma compared to EDTA-coated vacutainers. This can create differences in matrix effects and in recovery, depending on your sample preparation method.

I've seen a presentation by a French inspector at the EBF meeting in Barcelona in 2009. He reported two-fold differences in internal standard response between CPD and EDTA plasma, with also differences in retention times and peak width. You can expect this issue to be raised in case of an inspection.

Regards
Ohlbe

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
209 visitors (0 registered, 209 guests [including 13 identified bots]).
Forum time: 08:56 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5